ANIX · ISSUER CIK 715446
Anixa Biosciences Inc
Between Jul 31, 2026 and Oct 28, 2026, 4 Anixa Biosciences Inc insiders reported $293K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Titterton Lewis H jr (Director), with $183K.
↗4 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$293KInsider buying
$0.00Insider selling
+$293KNet open-market
Oct 26, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 202616:15 | Oct 23, 2026 | ANIX | Director | P · Buy | $2.98 | +8,000 | 1,054,003 | +1% | +$24K | -19.7% | +13.1% |
| Oct 22, 202617:44 | Oct 22, 2026 | ANIX | Chief Executive Officer, Director | P · Buy | $2.72 | +8,000 | 680,000 | +1% | +$22K | -26.7% | +23.9% |
| Sep 30, 202610:25 | Sep 30, 2026 | ANIX | President, COO, & CFO | P · Buy | $2.84 | +5,500 | 50,000 | +12% | +$16K | -24.3% | +18.7% |
| Sep 28, 202608:45 | Sep 24, 2026 | ANIX | Chief Executive Officer, Director | P · Buy | $2.78 | +7,000 | 672,000 | +1% | +$19K | -25.9% | +21.2% |
| Sep 28, 202608:30 | Sep 24, 2026 | ANIX | Director | P · Buy | $2.76 | +5,000 | 140,572 | +4% | +$14K | -26.4% | +22.1% |
| Sep 25, 202608:39 | Sep 23, 2026 | ANIX | Director | P · Buy | $2.69 | +49,036 | 1,046,003 | +5% | +$132K | -28.3% | +25.3% |
| Sep 14, 202609:45 | Sep 10, 2026 | ANIX | Chief Executive Officer, Director | P · Buy | $2.75 | +3,000 | 665,000 | +0% | +$8K | -26.7% | +22.5% |
| Sep 14, 202609:15 | Sep 10, 2026 | ANIX | Director | P · Buy | $2.73 | +10,000 | 996,967 | +1% | +$27K | -27.2% | +23.4% |
| Sep 11, 202608:00 | Sep 10, 2026 | ANIX | Chief Executive Officer, Director | P · Buy | $2.76 | +5,000 | 662,000 | +1% | +$14K | -26.4% | +22.1% |
| Aug 3, 202608:45 | Jul 31, 2026 | ANIX | Chief Executive Officer, Director | P · Buy | $3.47 | +5,000 | 657,000 | +1% | +$17K | -7.5% | -2.9% |